AR051890A1 - Tioeteres de tripeptido y tetrapeptido - Google Patents
Tioeteres de tripeptido y tetrapeptidoInfo
- Publication number
- AR051890A1 AR051890A1 ARP060100042A ARP060100042A AR051890A1 AR 051890 A1 AR051890 A1 AR 051890A1 AR P060100042 A ARP060100042 A AR P060100042A AR P060100042 A ARP060100042 A AR P060100042A AR 051890 A1 AR051890 A1 AR 051890A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- bone marrow
- 3alkyl
- heteroaryl
- gamma
- Prior art date
Links
- 210000001185 bone marrow Anatomy 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000005690 diesters Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000001992 L-gamma-glutamyl group Chemical group N[C@@H](CCC(=O)*)C(=O)O 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000973 chemotherapeutic effect Effects 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000003028 elevating effect Effects 0.000 abstract 1
- 230000011132 hemopoiesis Effects 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
- 230000003039 myelosuppressive effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 150000003568 thioethers Chemical class 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64193205P | 2005-01-06 | 2005-01-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051890A1 true AR051890A1 (es) | 2007-02-14 |
Family
ID=36123437
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060100041A AR051889A1 (es) | 2005-01-06 | 2006-01-05 | Sulfonas de tripeptido y tetrapeptido |
| ARP060100042A AR051890A1 (es) | 2005-01-06 | 2006-01-05 | Tioeteres de tripeptido y tetrapeptido |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060100041A AR051889A1 (es) | 2005-01-06 | 2006-01-05 | Sulfonas de tripeptido y tetrapeptido |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7129215B2 (enExample) |
| EP (2) | EP1833978B1 (enExample) |
| JP (2) | JP4903716B2 (enExample) |
| KR (2) | KR101244609B1 (enExample) |
| CN (2) | CN101090977B (enExample) |
| AR (2) | AR051889A1 (enExample) |
| AT (2) | ATE410520T1 (enExample) |
| AU (2) | AU2006204022B2 (enExample) |
| BR (2) | BRPI0606520A2 (enExample) |
| CA (2) | CA2587284C (enExample) |
| DE (2) | DE602006003064D1 (enExample) |
| DK (2) | DK1833978T3 (enExample) |
| EA (2) | EA200701398A1 (enExample) |
| ES (2) | ES2314890T3 (enExample) |
| HR (2) | HRP20090128T3 (enExample) |
| IL (2) | IL182836A (enExample) |
| MX (2) | MX2007008255A (enExample) |
| NZ (2) | NZ555362A (enExample) |
| PL (2) | PL1833978T3 (enExample) |
| PT (2) | PT1833978E (enExample) |
| SI (2) | SI1833978T1 (enExample) |
| TW (2) | TWI317738B (enExample) |
| WO (2) | WO2006074249A1 (enExample) |
| ZA (2) | ZA200704487B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8198247B2 (en) * | 2004-12-21 | 2012-06-12 | Telik, Inc. | Process for and intermediates in the preparation of canfosfamide and its salts |
| NZ555362A (en) * | 2005-01-06 | 2009-05-31 | Telik Inc | Tripeptide and tetrapeptide thioethers |
| US20070154963A1 (en) * | 2005-12-30 | 2007-07-05 | Danying Cai | Method to determine whether a compound is a cellular GSTpi inhibitor |
| US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
| US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
| AU2016213759B2 (en) * | 2006-11-08 | 2018-03-29 | Chongxi Yu | Transdermal delivery systems of peptides and related compounds |
| AU2006350707A1 (en) * | 2006-11-08 | 2008-05-15 | Chongxi Yu | Transdermal delivery systems of peptides and related compounds |
| MX377501B (es) | 2007-06-04 | 2025-03-10 | Techfields Inc | Profarmacos de nsaias con el piel y membranas con indices de penetracion muy altos y nuevos usos medicinales. |
| CN108191846B (zh) | 2008-12-04 | 2021-08-20 | 于崇曦 | 高穿透性组合物及其应用 |
| DE102008060888A1 (de) | 2008-12-09 | 2010-06-10 | Evonik Stockhausen Gmbh | Verfahren zur Herstellung von Acrolein umfassend die Aufarbeitung einer Rohglycerin-Phase |
| CN102459313A (zh) | 2009-05-08 | 2012-05-16 | 上海泰飞尔生化技术有限公司 | 多肽和多肽相关化合物的高穿透力前药组合物 |
| WO2011156045A2 (en) * | 2010-06-07 | 2011-12-15 | Telik, Inc. | Tablet formulation of ezatiostat |
| WO2011156061A1 (en) | 2010-06-07 | 2011-12-15 | Telik, Inc. | Preparation of crystalline ezatiostat hydrochloride ansolvate form d |
| US20130035389A1 (en) * | 2011-08-05 | 2013-02-07 | Telik, Inc. | Methods for treating myelodysplastic syndrome with ezatiostat |
| JP5970439B2 (ja) * | 2013-09-20 | 2016-08-17 | チョンシー ユー | ペプチド及び関連化合物の経皮送達システム |
| CN106146616A (zh) * | 2015-04-03 | 2016-11-23 | 浙江海正药业股份有限公司 | 环肽类化合物及其制备和用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599903A (en) * | 1992-04-03 | 1997-02-04 | Terrapin Technologies, Inc. | Glutathione analogs and paralog panels comprising glutathione mimics |
| US5786336A (en) * | 1991-04-29 | 1998-07-28 | Terrapin Technologies, Inc. | Target-selective protocols based on mimics |
| US5556942A (en) * | 1991-04-29 | 1996-09-17 | Terrapin Technologies, Inc. | Glutathione S-transferase-activated compounds |
| US5955432A (en) * | 1992-04-03 | 1999-09-21 | Terrapin Technologies, Inc. | Metabolic effects of certain glutathione analogs |
| US5767086A (en) * | 1992-04-03 | 1998-06-16 | Terrapin Technologies, Inc. | Bone marrow stimulation by certain glutathione analogs |
| CA2105492C (en) * | 1993-09-03 | 2000-02-01 | Lawrence M. Kauvar | Glutathione analogs and paralog panels comprising glutathione mimics |
| US5908919A (en) * | 1993-10-01 | 1999-06-01 | Terrapin Technologies | Urethane mediated, GST specific molecular release systems |
| JPH11507056A (ja) * | 1995-06-07 | 1999-06-22 | テラピン テクノロジーズ、インク． | グルタチオンアナログの代謝的効果 |
| GB2332676B (en) * | 1996-09-02 | 2001-01-24 | Univ Manchester Metropolitan | S-Blocked glutathiones |
| AU766515B2 (en) * | 1998-04-16 | 2003-10-16 | Teijin Limited | Glutathione derivatives and dosage forms thereof |
| KR100750842B1 (ko) | 1999-01-27 | 2007-08-22 | 텔리크 인코포레이티드 | 글루타티온 유사체를 함유하는 치료 조성물 |
| US7029695B2 (en) * | 2001-07-10 | 2006-04-18 | Telik, Inc. | Therapeutic compositions containing glutathione analogs |
| TWI323662B (en) * | 2002-11-15 | 2010-04-21 | Telik Inc | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| NZ555362A (en) * | 2005-01-06 | 2009-05-31 | Telik Inc | Tripeptide and tetrapeptide thioethers |
-
2006
- 2006-01-04 NZ NZ555362A patent/NZ555362A/en not_active IP Right Cessation
- 2006-01-04 EA EA200701398A patent/EA200701398A1/ru unknown
- 2006-01-04 TW TW095100277A patent/TWI317738B/zh not_active IP Right Cessation
- 2006-01-04 PT PT06717426T patent/PT1833978E/pt unknown
- 2006-01-04 DK DK06717426T patent/DK1833978T3/da active
- 2006-01-04 HR HR20090128T patent/HRP20090128T3/xx unknown
- 2006-01-04 KR KR1020077018022A patent/KR101244609B1/ko not_active Expired - Fee Related
- 2006-01-04 JP JP2007550441A patent/JP4903716B2/ja not_active Expired - Fee Related
- 2006-01-04 MX MX2007008255A patent/MX2007008255A/es active IP Right Grant
- 2006-01-04 CN CN2006800014949A patent/CN101090977B/zh not_active Expired - Fee Related
- 2006-01-04 PL PL06717426T patent/PL1833978T3/pl unknown
- 2006-01-04 CA CA2587284A patent/CA2587284C/en not_active Expired - Fee Related
- 2006-01-04 DE DE602006003064T patent/DE602006003064D1/de not_active Expired - Lifetime
- 2006-01-04 AT AT06717426T patent/ATE410520T1/de active
- 2006-01-04 US US11/325,846 patent/US7129215B2/en not_active Expired - Fee Related
- 2006-01-04 SI SI200630153T patent/SI1833978T1/sl unknown
- 2006-01-04 BR BRPI0606520-1A patent/BRPI0606520A2/pt not_active IP Right Cessation
- 2006-01-04 WO PCT/US2006/000219 patent/WO2006074249A1/en not_active Ceased
- 2006-01-04 EP EP06717426A patent/EP1833978B1/en not_active Expired - Lifetime
- 2006-01-04 ES ES06717426T patent/ES2314890T3/es not_active Expired - Lifetime
- 2006-01-04 TW TW095100278A patent/TWI317739B/zh not_active IP Right Cessation
- 2006-01-04 AU AU2006204022A patent/AU2006204022B2/en not_active Ceased
- 2006-01-05 AR ARP060100041A patent/AR051889A1/es not_active Application Discontinuation
- 2006-01-05 CA CA2587310A patent/CA2587310C/en not_active Expired - Fee Related
- 2006-01-05 DE DE602006003063T patent/DE602006003063D1/de not_active Expired - Lifetime
- 2006-01-05 DK DK06717699T patent/DK1833842T3/da active
- 2006-01-05 US US11/326,975 patent/US7192918B2/en not_active Expired - Fee Related
- 2006-01-05 SI SI200630154T patent/SI1833842T1/sl unknown
- 2006-01-05 PT PT06717699T patent/PT1833842E/pt unknown
- 2006-01-05 ES ES06717699T patent/ES2314891T3/es not_active Expired - Lifetime
- 2006-01-05 AR ARP060100042A patent/AR051890A1/es not_active Application Discontinuation
- 2006-01-05 AT AT06717699T patent/ATE410440T1/de active
- 2006-01-05 WO PCT/US2006/000532 patent/WO2006074409A1/en not_active Ceased
- 2006-01-05 KR KR1020077012531A patent/KR20070091611A/ko not_active Ceased
- 2006-01-05 MX MX2007008254A patent/MX2007008254A/es active IP Right Grant
- 2006-01-05 BR BRPI0606396-9A patent/BRPI0606396A2/pt not_active IP Right Cessation
- 2006-01-05 AU AU2006203901A patent/AU2006203901B2/en not_active Ceased
- 2006-01-05 PL PL06717699T patent/PL1833842T3/pl unknown
- 2006-01-05 JP JP2007550515A patent/JP4903717B2/ja not_active Expired - Fee Related
- 2006-01-05 EP EP06717699A patent/EP1833842B1/en not_active Expired - Lifetime
- 2006-01-05 HR HR20090134T patent/HRP20090134T3/xx unknown
- 2006-01-05 NZ NZ555361A patent/NZ555361A/en not_active IP Right Cessation
- 2006-01-05 EA EA200701399A patent/EA200701399A1/ru unknown
- 2006-01-05 CN CNA2006800013664A patent/CN101080418A/zh active Pending
-
2007
- 2007-04-26 IL IL182836A patent/IL182836A/en not_active IP Right Cessation
- 2007-05-10 IL IL183107A patent/IL183107A/en not_active IP Right Cessation
- 2007-05-20 ZA ZA200704487A patent/ZA200704487B/xx unknown
- 2007-05-30 ZA ZA200704488A patent/ZA200704488B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR051890A1 (es) | Tioeteres de tripeptido y tetrapeptido | |
| CY1112084T1 (el) | Παραγωγα 5-φαινυλθειαζολης και χρηση ως αναστολεις της κινασης ρi3 | |
| SV2008002969A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| AR029226A1 (es) | Tioamidas, composiciones farmaceuticas y el uso de la misma para la fabricacion de compuestos medicinales | |
| AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
| BRPI0507653A (pt) | derivados de imidazopiridina e imidazopiridina formulação farmacêutica compreendendo os mesmos e uso | |
| HRP20080113T3 (hr) | Supstituirani piridinilni i pirimidinilni derivati kao modulatori metabolizma i liječenje bolesti koje su s tim povezane | |
| AR018686A1 (es) | Compuestos de 1-piperidil benzoimidazol 2-sustituidos como agonistas de receptores orl1, composicion farmaceutica, su uso en medicina, procedimiento de preparacion e intermediarios | |
| AR045595A1 (es) | Composiciones utiles como inhibidores de proteinas quinasas | |
| AR029210A1 (es) | DERIVADOS DE N-(5-SULFAMOIL-1,3-TIAZOL-2-IL) ACETAMIDA, PROCEDIMIENTO PARA SU PREPARACIoN, COMPUESTOS INTERMEDIARIOS, COMPOSICIoN FARMACÉUTICA, Y EL USO DE DICHOS DERIVADOS PARA LA PRODUCCIoN DE MEDICAMENTOS | |
| UY31334A1 (es) | 3a,4,5,6,7,7a-hexahidro-3h-benzoimidazol y derivaods de 3a, 4,5,6,,7,7a-hexahidro-3-indol, enantiómeros, diastereoisómeros, sales farmacéuticamente aceptadas, mezclas, composiciones, preparaciones y aplicaciones de las mismas | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| SE0402925D0 (sv) | Novel Compounds | |
| IL163625A0 (en) | Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same | |
| TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| SG145570A1 (en) | 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
| MXPA05013050A (es) | Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos. | |
| AR024219A1 (es) | COMPUESTOS DE QUINOLONAS 2-(NH- U O-SUSTITUIDAS) UTILES COMO INHIBIDORES DE LA METIONIL t-RNA SINTETASA (MRS) COMPOSICIONES FARMACEUTICAS FORMULADAS CONDICHOS COMPUESTOS; PROCEDIMIENTO PARA SU PREPARACION Y USO DE DICHOS COMPUESTOS PARA PREPARAR MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIONES BACTER | |
| IL173809A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| AR046212A1 (es) | Derivados de 2-fenilbenzofurano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| AR043850A1 (es) | Acidos hidroxamicos utiles en el tratamiento de trastornos hiperproliferativos | |
| AR055096A1 (es) | Inhibidores de 6 -alquiliden -penem beta - lactamasa biciclicos y combinacion de antibioticos de beta - lactama : un antibiotico de amplio espectro | |
| AR050101A1 (es) | Oxazolidinonas que contienen oxindoles como agentes antibacterianos. | |
| AR055097A1 (es) | Inhibidores de 6- alquiliden - penem beta - lactamasa triciclicos y combinacion de antibioticos de beta lactama : un antibiotico de amplio espectro | |
| ATE307131T1 (de) | Phenanthrolin-7-onderivate und ihre therapeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |